Cygnus Technologies

CAP cell HCP ELISA kit

Product Description

  • The CAP®cell line, being of human origin, provides recombinant proteins with human-type glycosylation and is commonly employed in the production of recombinant proteins, gene therapy products, and vaccines.
  • CAP® cell line is a CEVEC Pharmaceuticals GmbH core proprietary technology.
  • Validated for testing of final product HCPs using actual in-process and final drug substance samples from a drug product.
  • LOD of ~0.9ng/mL.

Resources

Product Options

Product Number Description Package Size List Price (CAD)
CYGF820 CAP® Cell Line HCP ELISA Kit 1 kit -- Add to Cart

List Prices are displayed.

Please register or log-in to the site to view your organization’s prices, or please add the products to your cart and click the “Request a Quote” button to receive price and availability information (include quantities for each product and indicate either a one-time purchase or your annual usage.)